Intuitive Surgical stock heads into the open after a 2.4% gain
Published on 09/16/2026 at 08:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Intuitive Surgical stock closed at USD 377.94 on Nasdaq on September 14, 2026, gaining 2.38% compared with the prior close in the latest completed session. The move left the shares trading only a few dollars above a recent 52-week low, underscoring continued volatility in the name relative to broader US equity benchmarks.
September 14, 2026 in numbers
Intuitive Surgical Inc. (ISIN US46120E6023, Nasdaq: ISRG) finished the September 14, 2026 session at USD 377.94 on Nasdaq, up 2.38% from the previous close, according to Nasdaq data cited by market overviews. A recent analyst wrap noted that the company’s shares had closed last Friday at USD 369.15, close to a 52-week low of USD 364.17, highlighting how the latest rebound still leaves the stock near the bottom of its one-year range, as reported by The Globe and Mail. In an otherwise weak US equity environment, the stock’s 2.38 percent advance on September 14, 2026 stood out against more muted index moves, as summarized by a market report on the name from ad-hoc-news.
The same report pointed to continued recovery after earlier pressure that had brought Intuitive Surgical close to its 52-week low, while still leaving the shares below a recent 52-week high, framing the September 14, 2026 close of USD 377.94 within that broader range, according to ad-hoc-news. Against this backdrop, the latest completed session showed Intuitive Surgical modestly outperforming major US indices while still trading at a discount to its one-year peak levels, giving investors a clearer sense of where the stock sits in its recent trading band heading into today’s open.
Study results and events today
Today, attention around Intuitive Surgical is shaped in part by new clinical data on outcomes with its da Vinci robotic surgery system. A detailed study released on September 15, 2026 found that procedures performed with da Vinci were associated with better patient outcomes across 13 common conditions compared with traditional techniques, as discussed by Yahoo Finance and further analyzed by Zacks. The positive clinical findings may influence sentiment toward the stock today by reinforcing the perceived clinical value of the company’s installed surgical systems and supporting procedure growth expectations.
Beyond company-specific news, investors in Intuitive Surgical today also consider the broader backdrop for US healthcare and growth stocks, with the latest recovery in the shares from levels near a 52-week low on September 14, 2026 providing context for how the stock might react to any new macro or sector data. With no major company-specific scheduled events confirmed for the next few days in the available calendars, the shares head into the open primarily framed by the recent price recovery from USD 369.15 to USD 377.94 and the fresh da Vinci outcomes evidence, both of which shape expectations for how Intuitive Surgical trades in the coming session.
